Transplantation of microencapsulated umbilical-cord-blood-derived hepatic-like cells for treatment of hepatic failure

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 7

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

436

HTML

3901

Figures (1-6)

248

Tables (1-2)

250

Sum=4835

Feb 21, 2011 (publication date) through Dec 25, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Feb 21, 2011; 17(7): 938-945
Published online Feb 21, 2011. doi: 10.3748/wjg.v17.i7.938

Full Size Figure Download Figure

Figure 1 FACS determination of CD34⁺ cells. A: Purity of CD34⁺ cells; B: Homotypic control cells.

Citation: Zhang FT, Wan HJ, Li MH, Ye J, Yin MJ, Huang CQ, Yu J. Transplantation of microencapsulated umbilical-cord-blood-derived hepatic-like cells for treatment of hepatic failure. World J Gastroenterol 2011; 17(7): 938-945
URL: https://www.wjgnet.com/1007-9327/full/v17/i7/938.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i7.938